Clinical Trials List
2020-10-20 - 2022-04-28
Phase III
Not yet recruiting2
Recruiting2
ICD-10D47.3
Essential (hemorrhagic) thrombocythemia
ICD-10D69.3
Immune thrombocytopenic purpura
ICD-10D69.41
Evans syndrome
ICD-10D69.42
Congenital and hereditary thrombocytopenia purpura
ICD-10D69.49
Other primary thrombocytopenia
ICD-9287.3
Primary thrombocytopenia
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chia-Jen Liu Division of Hematology & Oncology
- Po-Shen Ko Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Hao-Yuan Wang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Chung Kao Division of Hematology & Oncology
- Jin-Hou Wu Division of Hematology & Oncology
- Tung-Liang Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 何景良 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
- 吳宜穎 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6~8 participants
-
Global
105 participants
